Focus on Pathways: Targeting the CSF-1R Pathway in Graft-vs-Host Disease - Episode 4
Clinical Scenario and Perspectives on the Evolving Treatment Landscape in GVHD
Dr. Hannah Choe discusses a clinical scenario of a patient with GVHD who has progressed after multiple lines of treatment. She explores how the availability of CSF-1R inhibitors could fit into the evolving treatment landscape for managing this difficult-to-treat patient population. Dr. Choe provides her perspectives on the potential role and clinical implications of targeting this pathway as an emerging therapeutic approach for GVHD.
Video Player is loading.
Related Content:
